Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?
Buch
Maya H
MH
Leeds Teaching Hospital, Leeds, UK.
Emery
Paul
P
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D011379:Prognosis; D019233:Retreatment; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha